Library / Laws / 117th / hr / H.R. 679 / Introduced in House
I
117th CONGRESS
1st Session
H. R. 679
IN THE HOUSE OF REPRESENTATIVES
February 1, 2021Mr. Trone (for himself and Mr. Burchett) introduced the following bill; which was referred to the Committee on Oversight and Reform, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
A BILL
To amend the Office of National Drug Control Policy Reauthorization Act of 1998 to direct the Office of National Drug Control Policy to publish a list of drug control grant programs, and for other purposes.
1.
Short title
This Act may be cited as the Effective Drug Control Strategy Act of 2021.
2.
Federal drug demand reduction activities
(a)
Publication of list
(1)
Amendment
Section 705(f) of the Office of National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1704(f)) is amended by inserting at the end the following new paragraph:
(5)
Publication of list
The Director shall publish online a complete list of all drug control program grant programs and any other relevant information included in the information tracked pursuant to paragraph (1).
.
(2)
Deadline and frequency
Not later than one year after the date of the enactment of this Act, and annually thereafter, the Director of National Drug Control Policy shall publish the list required under section 705(f)(5) of the National Drug Control Act of 1998, as added by paragraph (1).
(b)
National Drug Control Strategy
Section 706(c)(1) of the Office of National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1705(c)(1)) is amended by adding at the end the following new subparagraph:
(O) A review of all federally funded demand reduction activities, including an evaluation of—
(i) the effectiveness of those activities;
(ii) the contribution of those activities to demand reduction activities funded by State, local, and Tribal governments; and
(iii) whether any duplication or inefficiency in federally funded demand reduction activities needs to be addressed.
.